The relationship between small intestinal bacterial overgrowth and constipation in children - a comprehensive review

Cristina Roxana Mares1, Maria Oana Săsăran2, Cristina Oana Mărginean3

  • 1Department of Pediatrics, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology of Târgu Mures, Târgu Mures, Romania.

Insights

Small intestinal bacterial overgrowth (SIBO) in children can cause various digestive issues. This review examines current treatments for pediatric SIBO with constipation, highlighting limited research on antibiotic efficacy.

Area of Science:

  • Gastroenterology
  • Pediatric Medicine
  • Microbiology

Background:

  • Small intestinal bacterial overgrowth (SIBO) involves excessive bacteria in the small intestine, leading to diverse pediatric symptoms from mild GI upset to malnutrition.
  • Methanogenic bacteria overgrowth is linked to constipation, a common symptom in pediatric SIBO.
  • Noninvasive breath tests are used for SIBO diagnosis, but lack standardized methodology.

Purpose of the Study:

  • To review the current understanding of SIBO in pediatric patients with constipation.
  • To discuss existing and emerging treatment strategies for pediatric SIBO and constipation.
  • To highlight the limitations and conflicting results in current research on antibiotic treatments for this population.

Main Methods:

  • Literature review summarizing the state-of-the-art in pediatric SIBO and constipation.
  • Analysis of previous and current treatment regimens, including antibacterial therapy, dietary adjustments, and management of underlying conditions.
  • Focus on evidence pertaining to pediatric populations.

Main Results:

  • SIBO presents a wide symptom spectrum in children, impacting digestion and nutrient absorption.
  • A correlation exists between intestinal methanogenic bacteria and constipation.
  • Research on antibiotic efficacy for pediatric SIBO with constipation is limited and shows inconsistent findings.

Conclusions:

  • Effective management of pediatric SIBO with constipation requires a multi-faceted approach.
  • Further research is crucial to establish standardized diagnostic methods and evidence-based antibiotic treatments for children.
  • Addressing underlying conditions and optimizing diet are essential components of SIBO management in pediatric patients.

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...